Neurophysiological Assessment of Spinal Excitability in Chronic Low Back Pain
Chronic Low-back Pain
About this trial
This is an interventional screening trial for Chronic Low-back Pain
Eligibility Criteria
Inclusion Criteria:
- patients suffering from chronic low back pain for more than 12 Weeks.
Exclusion Criteria:
- Patients who are suspected of suffering from any autoimmune, rheumatological disorders that could explain the pain that they experienced will be excluded from the study.
- Patients who are suffering from any disease that could affect the results and interpretation of the parameters of the H-reflex, F-wave or SSEP, including polyneuropathy and radiculopathy.
- Patients who are suffering from any Structural Spinal cause of pain will be excluded by relative investigations.
Sites / Locations
- Sohag University Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
patients with chronic low back pain
healthy controls
50 Patients will be recruited from neuropsychiatric outpatient clinic at Sohag University Hospital complaining of CLBP for more than 12 Weeks. Patients who are suspected of suffering from any autoimmune, rheumatological, or neurological disorders that could explain the pain that they experienced will be excluded from the study. Patients who are suffering from any disease that could affect the results and interpretation of the parameters of the H-reflex, F-wave or SSEP, including polyneuropathy and radiculopathy. Structural Spinal cause of pain will be excluded by relative investigations. Routine nerve conduction studies on both lower limbs as well as H-reflex, F-wave and SSEP will be performed on both patients and controls.Arabic versions of the Beck depression inventory and Taylor's Manifest Anxiety Scale will be used to measure depression and anxiety in both patients and healthy controls.
50 Healthy volunteers will be included in the control group of the study. Routine nerve conduction studies on both lower limbs as well as H-reflex, F-wave and SSEP will be performed on both patients and controls. Arabic versions of the Beck depression inventory and Taylor's Manifest Anxiety Scale (TMAS) will be used to measure depression and anxiety in both patients and healthy controls.